Financials Mankind Pharma Limited

Equities

Market Closed - NSE India S.E. Other stock markets 05:19:42 11/07/2025 pm IST			5-day change	1st Jan Change
2,578.30 ^INR	+1.35%		+5.69%	-10.49%

11/07	Jefferies Adjusts Mankind Pharma's Price Target to INR3,000 From INR2,870, Keeps at Buy	MT
30/06	India's Torrent Pharma to acquire controlling stake in JB Chem and Pharma	RE

Fiscal Period: March	2022	2023	2024	2025	2026	2027
Net sales ¹	-	87,494	1,03,348	1,22,074	1,48,236	1,66,918
Change	-	-	18.12%	18.12%	21.43%	12.6%
EBITDA ¹	-	19,006	25,351	30,179	38,630	45,133
Change	-	-	33.38%	19.05%	28%	16.83%
EBIT ¹	-	15,747	21,368	23,967	30,139	36,172
Change	-	-	35.7%	12.16%	25.75%	20.02%
Interest Paid ¹	-	-444.7	-335.3	-4,294	-5,809	-3,970
Earnings before Tax (EBT) ¹	-	16,712	23,994	25,163	26,485	35,151
Change	-	-	43.57%	4.88%	5.25%	32.72%
Net income ¹	14,335	12,819	19,129	19,910	20,959	27,142
Change	-	-10.58%	49.23%	4.08%	5.27%	29.5%
Announcement Date	01/08/22	30/05/23	15/05/24	21/05/25	-	-

¹INR in Million

Estimates

Fiscal Period: March	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales ¹	25,786	27,081	26,070	24,411	28,934	30,765	32,300	30,904	35,975	38,763	37,213	33,576
Change	-	5.02%	-3.73%	-6.36%	18.53%	6.33%	4.99%	-4.32%	16.41%	7.75%	-4%	-9.77%
EBITDA ¹	6,548	6,826	6,065	5,911	6,818	8,500	8,298	7,874	8,964	10,737	9,452	8,226
Change	-	4.25%	-11.15%	-2.54%	15.34%	24.68%	-2.38%	-5.11%	13.84%	19.78%	-11.97%	-12.97%
EBIT ¹	5,675	5,862	4,968	4,864	5,740	7,444	6,375	5,730	5,996	-	-	-
Change	-	3.3%	-15.25%	-2.09%	18.01%	29.69%	-14.36%	-10.12%	4.64%	-	-	-
Charge d'intérêts ¹	-	-	-	-	-109.1	-71	-2,209	-1,796	-1,447	-1,447	-1,447	-1,447
Earnings before Tax (EBT) ¹	6,245	6,410	5,623	5,716	6,676	8,493	4,973	4,399	5,422	7,372	6,180	5,173
Change	-	2.65%	-12.27%	1.64%	16.8%	27.22%	-41.44%	-11.54%	23.24%	35.98%	-16.17%	-16.29%
Net income ¹	4,869	5,010	4,538	4,712	5,365	6,535	3,802	3,497	4,330	5,941	4,957	4,097
Change	-	2.91%	-9.43%	3.85%	13.85%	21.8%	-41.81%	-8.02%	23.81%	37.21%	-16.56%	-17.35%
Announcement Date	02/08/23	31/10/23	31/01/24	15/05/24	31/07/24	05/11/24	23/01/25	-	-	-	-	-

¹INR in Million

Estimates

Fiscal Period: March	2022	2023	2024	2025	2026	2027
Net Debt ¹	-	-	-32,600	62,377	50,709	27,105
Change	-	-	-	291.34%	-24.58%	-46.55%
Announcement Date	01/08/22	30/05/23	15/05/24	21/05/25	-	-

¹INR in Million

Estimates

Fiscal Period: March	2023	2024	2025	2026	2027
CAPEX ¹	7,890	3,153	5,081	5,336	5,181
Change	-	-60.03%	61.14%	-95.1%	-2.89%
Free Cash Flow (FCF) ¹	10,243	18,371	19,052	25,576	29,877
Change	-	79.36%	3.71%	121.21%	16.81%
Announcement Date	30/05/23	15/05/24	21/05/25	-	-

¹INR in Million

Estimates

Fiscal Period: March	2022	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	-	21.72%	24.53%	24.72%	26.06%	27.04%
EBIT Margin (%)	-	18%	20.68%	19.63%	20.33%	21.67%
EBT Margin (%)	-	19.1%	23.22%	20.61%	17.87%	21.06%
Net margin (%)	-	14.65%	18.51%	16.31%	14.14%	16.26%
FCF margin (%)	-	11.71%	17.78%	15.61%	17.25%	17.9%
FCF / Net Income (%)	-	79.91%	96.04%	95.7%	122.03%	110.07%
Profitability
ROA	-	13.59%	17.65%	10.02%	9.74%	11.62%
ROE	-	18.86%	22.77%	16.8%	14.02%	15.79%
Financial Health
Leverage (Debt/EBITDA)	-	-	-	2.07x	1.31x	0.6x
Debt / Free cash flow	-	-	-	3.27x	1.98x	0.91x
Capital Intensity
CAPEX / Current Assets (%)	-	9.02%	3.05%	4.16%	3.6%	3.1%
CAPEX / EBITDA (%)	-	41.51%	12.44%	16.84%	13.81%	11.48%
CAPEX / FCF (%)	-	77.03%	17.16%	26.67%	20.86%	17.34%
Items per share
Cash flow per share ¹	-	45.27	53.65	59.64	67.95	85.06
Change	-	-	18.52%	11.16%	8.79%	25.18%
Dividend per Share ¹	-	-	-	9	7.8	10.42
Change	-	-	-	-	-13.33%	33.59%
Book Value Per Share ¹	-	185.6	233.7	347.4	392.1	451.7
Change	-	-	25.93%	48.62%	17.16%	15.19%
EPS ¹	35.78	32	47.68	49.2	50.52	66.09
Change	-	-10.56%	49%	3.19%	6.38%	30.82%
Nbr of stocks (in thousands)	-	-	4,00,588	4,12,729	4,12,729	4,12,729
Announcement Date	01/08/22	30/05/23	15/05/24	21/05/25	-	-